BioCentury
ARTICLE | Clinical News

ThermoDox heat-activated liposome regulatory update

August 30, 2010 7:00 AM UTC

FDA granted Orphan Drug designation for Celsion's ThermoDox plus radiofrequency ablation (RFA) to treat non-resectable hepatocellular carcinoma (HCC). The doxorubicin encapsulated in a heat-activated ...